Advertisement

Topics

MicroDose Therapeutx, Inc. Company Profile

04:18 EDT 25th March 2019 | BioPortfolio

MicroDose Therapeutx is a privately-held pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuses on developing proprietary products that address large unmet market opportunities, and on drug delivery platforms for the pulmonary, oral, and transdermal delivery of medications. The company develops its products and technologies independently, as well as in partnership with leading pharmaceutical companies. MicroDose’s products and platforms currently target respiratory disease states such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory syncytial virus (RSV), as well as IBS-C and constipation. More can be found at our website; www.mdtx.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Eyenovia Announces Publication of its PG21 Phase II Trial Results

Eyenovia (NASDAQ:EYEN) announced that the full results of its Phase II PG21 study have been published in the article “Latanoprost with high precision, piezo-print microdose delivery for IOP lowerin...

Eyenovia planning NDA in 1Q20 for microdose ophthalmic solution to induce mydriasis

Small 'microdoses' of psychedelic drugs could treat depression and anxiety

(American Chemical Society) Lava lamps, tambourines and, of course, psychedelic drugs were hallmarks of the 1960s. Psychedelic drugs can make people euphoric, though users can also become extremely an...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.

Stable isotope labeled (SIL) compounds have been commonly used as internal standards (IS) to ensure the accuracy and quality of liquid chromatography-mass spectrometry (LC-MS) bioanalytical assays. Re...

Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.

Phase 0 approaches, including microdosing, involve the use of sub-therapeutic exposures to the tested drugs, thus enabling safer, more-relevant, quicker and cheaper first-in-human (FIH) testing. These...

Clinical Trials [34 Associated Clinical Trials listed on BioPortfolio]

Intrathecal Morphine Microdose Method Sensory Changes

Following the retrospective study ont he effectiveness of the microdose method of IT morphine therapy, the investigators are interested in measuring the sensory changes at 4 time points du...

Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633

This study is a first administration to man microdose study to describe the pharmacokinetics of GSK2239633.

An Exploratory Phase 1 Microdose Study of PRX-105

Exploratory phase 1, first in human, open label, non-randomized, single-dose study of PRX-105, administered intravenously by slow bolus injection to 10 healthy volunteers. The objective i...

Phase 0 Microdose Study

This study is a methodology study to evaluate a microdose strategy for Drug-Drug Interaction (DDI) which will be useful in the evaluation of the backup compounds for GSK706769, as well as ...

Study of a Single Oral Dose of AZD9668 and Intra-venous (IV) Microdose of [C14] AZD9668 in Healthy Subjects

The primary objective of this study is to assess the absolute bioavailability and to evaluate pharmacokinetic parameters of a single oral dose and a radiolabelled intravenous microdose of ...

Companies [3 Associated Companies listed on BioPortfolio]

MicroDose Therapeutx Inc.

MicroDose Therapeutx is a privately-held specialty pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuse...

MicroDose Therapeutx, Inc.

MicroDose Therapeutx is a privately-held pharmaceutical company dedicated to improving the quality of life for people suffering from serious diseases. The company focuses on devel...

MicroDose Technologies, Inc.

MicroDose Technologies, Inc. is a privately held premier drug delivery and specialty pharmaceuticals company. Founded in 1998, MicroDose is pioneering the use of proprietary drug delivery platforms fo...

More Information about "MicroDose Therapeutx, Inc." on BioPortfolio

We have published hundreds of MicroDose Therapeutx, Inc. news stories on BioPortfolio along with dozens of MicroDose Therapeutx, Inc. Clinical Trials and PubMed Articles about MicroDose Therapeutx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MicroDose Therapeutx, Inc. Companies in our database. You can also find out about relevant MicroDose Therapeutx, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record